Trion Pharma Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 09293856 (England and Wales)

Financial Statements for the Year Ended 31 October 2021

for

Trion Pharma Limited

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

4

DIRECTOR:

Mr Vipulkumar Patel

REGISTERED OFFICE:

Bridge House

9-13 Holbrook Lane

Covnetry

West Midlands

CV6 4AD

REGISTERED NUMBER:

09293856 (England and Wales)

ACCOUNTANTS:

Sterling Accounting Services Limited

Bridge House

9-13 Holbrook Lane

Coventry

CV6 4AD

FIXED ASSETS

Tangible assets

4

163,508

18,764

CURRENT ASSETS

Debtors

5

2,109,489

677,653

Cash at bank and in hand

3,013,413

2,261,289

5,122,902

2,938,942

CREDITORS

Amounts falling due within one year

6

3,757,225

2,511,030

NET CURRENT ASSETS

1,365,677

427,912

TOTAL ASSETS LESS CURRENT LIABILITIES

1,529,185

446,676

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

1,529,085

446,576

SHAREHOLDERS' FUNDS

1,529,185

446,676

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 July 2022 and were signed by:

Mr Vipulkumar Patel - Director

1.	STATUTORY INFORMATION

Trion Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

20% on reducing balance

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2020 - 6 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 November 2020

25,005

Additions

186,511

At 31 October 2021

211,516

DEPRECIATION

At 1 November 2020

6,241

Charge for year

41,767

At 31 October 2021

48,008

NET BOOK VALUE

At 31 October 2021

163,508

At 31 October 2020

18,764

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.10.21

31.10.20

£

£

Trade debtors

877,069

294,338

Other debtors

1,232,420

383,315

2,109,489

677,653

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.10.21

31.10.20

£

£

Trade creditors

3,027,249

2,162,069

Taxation and social security

596,831

232,581

Other creditors

133,145

116,380

3,757,225

2,511,030

7.	CALLED UP SHARE CAPITAL

Allotted and issued:

Number:

Class:

Nominal

31.10.21

31.10.20

value:

£

£

100

Share capital 1

£1

100

100